Merck Cuts Pharma Revenue Guidance By $1.7bn Due To Pandemic

 
• By Joseph Haas
  
Quarterly resluts on typewriter close up
Merck enjoyed a strong first quarter but expects pandemic-related downturn in the second and third quarters
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business